Iodogen | C16H10Cl4N4O2 | ChemSpider
Idogen AB (publ) Org nr
Annual Report
Q3 ENG - Idogen
Idogen AB Year-end report
Idogen's cell technology successfully advanced to large-scale production
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
biotech | pharma | diagnostics | devices
Idogen presentation - Idogen
Idogen's IDO 8 granted orphan drug designation in the USA - Idogen
Idogen AB (publ)
BioInsights - Bringing advanced therapies to the clinic: the Swedish National ATMP Consortium (CAMP/SWElife ATMP)
Idogen AB | Aktiespararna
Redeye-intervju med Idogens VD om emissionsutfallet och rekryteringen av ny CMO - IPO.se
Idogen's Historical Milestones - Idogen
Idogen AB Interim report Idogen AB Interim report
Idogen aktieägargrupp | Facebook
niklas wallett - Idogen
PRESS RELEASE IDOGEN AB
Idogen's Historical Milestones - Idogen
Idogen - Engineering Immune Tolerance
Idogen AB Delårsrapport Januari–September 2019 | Tanalys
Idogen appoints Anders Karlsson as new CEO - Idogen
Idogen - Crunchbase Company Profile & Funding
